Abstract
Cytokine ELISPOT assays have emerged as a powerful tool for the detection of rare antigen-specific T cells in freshly isolated cell material, such as blood. While ELISPOT assays allow one to directly visualize and count extremely low frequencies of cytokine-secreting T cells among millions of nonsecreting bystander cells, the interpretation of ELISPOT data can become ambiguous when (a) spot numbers in antigen-containing wells are low, (b) spot counts in negative control wells are elevated, and particularly (c) when both of the above occur simultaneously. Thus, the primary task, even before statistics are employed, must be the optimization of the basic assay parameters and reagents such that the assay yields low background signal in the negative-control wells and the maximal number of antigen-induced spots in test wells, i.e., the signal-to-noise ratio is maximized. Furthermore, the use of proper spot-size gating parameters for data analysis is indispensable for screening out irrelevant background spots, and thus increasing the signal-to-noise ratio. The goal of most ELISPOT experiments is to identify positive T-cell responses as defined by a significantly elevated spot count in antigen-stimulated wells over the nonstimulated medium-control or negative-control antigen. In this chapter, we conclude that – with some limitations – the T-Test and related statistical methods which rely on the assumption of normal distribution are suitable for identifying positive ELISPOT results.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Forsthuber, T., Yip, H. C., and Lehmann, P. V. (1996) Induction of TH1 and TH2 immunity in neonatal mice. Science 271, 1728–1730.
Zhang, W., Caspell, R., Karulin, A. Y., Ahmad, M., Haicheur, N., Abdelsalam, A., et al. (2009) ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring – even in hands of ELISPOT-inexperienced investigators. J Immunotoxicol 6, 227–234.
Hesse, M. D., Karulin, A. Y., Boehm, B. O., Lehmann, P. V., and Tary-Lehmann, M. (2001) A T cell clone’s avidity is a function of its activation state. J Immunol 167, 1353–1361.
Kreher, C. R., Dittrich, M. T., Guerkov, R., Boehm, B. O., and Tary-Lehmann, M. (2003) CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays, J Immunol Methods 278, 79–93.
Ott, P. A., Tary-Lehmann, M., and Lehmann, P. V. (2007) The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell types, Clin Immunol 124, 267–276.
Nowacki, T. M., Kuerten, S., Zhang, W., Shive, C. L., Kreher, C. R., Boehm, B. O., et al. (2007) Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells. Cell Immunol 247, 36–48.
Guerkov, R. E., Targoni, O. S., Kreher, C. R., Boehm, B. O., Herrera, M. T., Tary-Lehmann, M., et al. (2003) Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J Immunol Methods 279, 111–121.
Moodie, Z., Price, L., Gouttefangeas, C., Mander, A., Janetzki, S., Lower, M., et al. (2010) Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother 59, 1489–1501.
Dubey, S., Clair, J., Fu, T. M., Guan, L., Long, R., Mogg, R., et al. (2007) Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. J Acquir Immune Defic Syndr 45, 20–27.
Hudgens, M. G., Self, S. G., Chiu, Y. L., Russell, N. D., Horton, H., and McElrath, M. J. (2004) Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J Immunol Methods 288, 19–34.
Moodie, Z., Huang, Y., Gu, L., Hural, J., and Self, S. G. (2006) Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. J Immunol Methods 315, 121–132.
R Development Core Team. (2009) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria.
Anderson, T. W., and Darling, D. A. (1952) Asymptotic Theory of Certain Goodness of Fit Criteria Based on Stochastic Processes. Ann Math Stat 23, 193–212.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Dittrich, M., Lehmann, P.V. (2012). Statistical Analysis of ELISPOT Assays. In: Kalyuzhny, A. (eds) Handbook of ELISPOT. Methods in Molecular Biology, vol 792. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-325-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-61779-325-7_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-324-0
Online ISBN: 978-1-61779-325-7
eBook Packages: Springer Protocols